Oncoplant Therapeutics
Milestone-driven oncology biotech
Science Team
Science
Finalist South Dakota Governor’s Giant Vision • Oncology Therapeutics

De-risking a first-in-class, tumor-responsive therapy for metastatic colorectal cancer.

Oncoplant is a South Dakota–based development-stage biotech advancing VTD-NP, a veratridine-enabled nanotherapeutic designed for metastatic colorectal cancer with hepatic involvement. Our near-term product is validated data—built through disciplined, go/no-go milestones—enabling partnering, licensing, or acquisition.

Team

Science Overview

Khosrow Rezvani MD, Ph.D.

CEO
Cancer biology • metastatic CRC
Khosrow Rezvani headshot

Associate Professor of Cancer Biology
Sanford School of Medicine, University of South Dakota
khosrow.rezvani@usd.edu

Grigoriy Sereda, Ph.D.

Chief Scientist
Materials chemistry • nanoparticle delivery
Grigoriy Sereda headshot

Professor of Chemistry
University of South Dakota
grigoriy.sereda@usd.edu